Randwick Precinct Cancer Roundtable - Drug Development [July 31st 2018]

Image - Randwick Precinct Cancer Roundtable - Drug Development [July 31st 2018]

Topic: Drug Development

Invited speaker: Prof Peter Gunning

Facilitator: Prof Michael Friedlander

Interactive discussion facilitated by Prof Michael Friedlander

Conjoint Professor of Medicine , UNSW Sydney

Michael Friedlander is a medical oncologist at Prince of Wales and Royal Hospital for Women with a particular interest in breast and ovarian cancers.

Invited speaker – Prof Peter Gunning

Head of the School of Medical Sciences, UNSW Sydney

Professor Peter Gunning is a cell biologist who has discovered new principles of cell architecture and applied this knowledge to the development of anti-cancer drugs. He has also served as a member of the Boards of both the NSW Cancer Council and the Cancer Institute NSW (current) and has been the Chair of the Research Committees of both institutions.

Topics for discussion

1. First identify your target

2. Make a new type of drug

3. Does it improve current therapy?

4. What’s the indication?

5. The path to the clinic

Event date: 
Tue, 31/07/2018 - 12:00pm to 1:30pm
Edmund Blacket Functions Room, Prince of Wales Hospital
Open to: 
Number of seats available: 
Event Type: 
In Conversation


"At first a felt a bit funny about talking to a lady about my problems after my cancer treatment, but my doctor is really nice and really understanding.  Plus she is an oncologist so she understands all the medical stuff that goes along with cancer treatment so I didn't have to explain things to her the way I did to my GP.  I felt like she really understood where I was coming from and gave me some good strategies to help with my issues.  And she wrote a care plan and sent a copy to my GP as well, so hopefully now when I go to see him he will feel like he is better able to treat me."

Anthony, prostate cancer survivor
"At 26 I was diagnosed with a rare form of ovarian cancer... having survived this (thanks to a great medical team), I ‘floundered’ for many years with the resulting impact of early menopause, fertility issues and general fatigue. Even worse, I felt extreme guilt that I should be able to overcome these issues easily as I survived when others didn’t, I really didn’t have the right to ever complain again. This impacted directly on my confidence, self esteem and identity. ……I am now 46, have 2 children, a partner, a career and a good life.  However, the struggle I had undergone, in pretty much isolation, has been hard.  Even friends and family who were great during treatment felt I should ‘just move on’.  The establishment of this centre is a great comfort as it shows there is now a greater awareness of cancer survivor issues to hopefully ensure better long term support for people who have had cancer."

Melinda, ovarian cancer survivor 
"I am aware of the National Centre for Cancer Survivorship and support them in their mission to find new and better ways to care for cancer survivors through research. With the high number of Australians now surviving cancer or living with ongoing cancer for many years, we need to better understand the health issues confronting this group and develop interventions to address their unique and often complex needs. As someone who has worked in the medical oncology setting for 20 years, I believe the National Centre for Cancer Survivorship is leading the way in this work."

Dr Elizabeth Hovey, MB BS FRACP MSC - Medical Oncologist, SESIAHS & UNSW, Prince of Wales Hospital
"As Director of the Kids Cancer Centre, Sydney Children’s Hospital and Professor of Paediatrics at the University of NSW, I have watched the development of the National Centre for Cancer Survivorship over the last few years. I strongly support the opportunity the Centre provides to bring together research focusing on survivors of childhood cancer with that focusing on adult survivors. In both areas it is clear that there are many unresolved challenges in understanding the health care needs of cancer survivors, and developing best practice interventions for both prevention and treatment of those problems. I believe wholeheartedly that the work that being undertaken through the Centre will benefit both kids and adult survivors people for many years to come."

Professor Glenn Marshall, AM, MB, BS, FRACP, MD Paediatric Haematologist & Oncologist, Director, Kids Cancer Centre, Sydney Children’s Hospital